Ascom Acquires the Italian Medical Software Company UMS

AscomAscom has acquired the Italian software company UMS (United Medical Software), which provides integrations for medical devices and supplies digital medical records software solutions for life-critical patient care. With the acquisition of UMS, Ascom will gain access to new software and competence for global integrated workflow solutions in Healthcare ICT. Moreover, Ascom will improve its market position in Italy significantly thanks to the UMS installed base.

UMS s.r.l. is a privately held medical software company based in the region of Florence. The company delivers modular, point-of-care, digital medical records software solutions for life-critical patient care. UMS solutions help clinicians treat patients facing life-critical outcomes, while filing the gaps in digital medical records technology. UMS offers more than 200 medical device integrations and 1,000 different EMR forms and integrations. UMS' customers include large university hospitals, private specialty clinics, and healthcare government entities. UMS has products ready for international deployment and installations in Europe. The Company produces CE-marked medical device software, and is a partner/supplier of large companies in the medical device business.

UMS has a well-established installed base, mainly in the Italian market, and is expected to achieve revenues in the range of EUR 3-4 million in 2015, with EBITDA margins comparable to the Ascom Wireless Solutions Division.

With this acquisition, Ascom will gain access to new software and additional competence for global integrated workflow solutions in Healthcare ICT. Ascom will leverage the acquired software solutions globally. Consequently, capabilities to integrate medical devices and therefore mission-critical data into existing Ascom workflow solutions and Ascom Myco will be increased. In addition, Ascom will be granted access to new solutions for intensive care and surgical workflow management in high acuity units. Finally, the acquisition will help Ascom reach previously underserved geographical areas and increase its market share in Italy and Southern Europe. The acquisition fits perfectly with Ascom’s strategy for achieving its 2020 ambitions.

Ascom signed an agreement to acquire all shares of the company UMS s.r.l. Closing is expected to take place in mid-January 2016. All 27 employees will be taken over at their existing location. The purchase price amounts to the mid-single digit millions in CHF. In addition, Ascom has agreed to an earn-out payment in the low-single digit millions in CHF, dependent on the achievement of agreed revenue targets.

Gabriele Unterberger, who founded and successfully led UMS, will continue to run the company, to be renamed "Ascom UMS s.r.l.", as its Managing Director.

"Ascom is very pleased to have acquired a business with such a good strategic fit. This is an important technology acquisition for Ascom’s Healthcare ICT strategy. With the acquired software solutions, we have the opportunity to give our customers even more possibilities to improve their clinical workflows. In addition, we will gain direct access to the Italian market. This transaction accelerates Ascom’s roadmap for its integration capabilities and is the next step in building and strengthening the leading position of Wireless Solutions in the global healthcare communications market," underlines Claes Ödman, General Manager Ascom Wireless Solutions.

About Ascom
Ascom is an international solutions provider with comprehensive know-how in healthcare workflows and telecommunications. The company is active in Wireless Solutions (an international market leader for high-value, customer-specific on-site communication solutions and workflow optimization) and Network Testing (a global market leader in testing, monitoring, post processing, and performance optimization for mobile networks). The Ascom Group is headquartered in Switzerland, has subsidiaries in 19 countries and employs around 1,700 people worldwide. Ascom registered shares (ASCN) are listed on the SIX Swiss Exchange in Zurich.

Most Popular Now

Research Shows AI Technology Improves Pa…

Existing research indicates that the accuracy of a Parkinson's disease diagnosis hovers between 55% and 78% in the first five years of assessment. That's partly because Parkinson's sibling movement disorders...

AI in Healthcare: How do We Get from Hyp…

The Highland Marketing advisory board met to consider the government's enthusiasm for AI. To date, healthcare has mostly experimented with decision support tools, and their impact on the NHS and...

Who's to Blame When AI Makes a Medi…

Assistive artificial intelligence technologies hold significant promise for transforming health care by aiding physicians in diagnosing, managing, and treating patients. However, the current trend of assistive AI implementation could actually...

First Therapy Chatbot Trial Shows AI can…

Dartmouth researchers conducted the first clinical trial of a therapy chatbot powered by generative AI and found that the software resulted in significant improvements in participants' symptoms, according to results...

DMEA sparks: The Future of Digital Healt…

8 - 10 April 2025, Berlin, Germany. Digitalization is considered one of the key strategies for addressing the shortage of skilled workers - but the digital health sector also needs qualified...

DeepSeek: The "Watson" to Doct…

DeepSeek is an artificial intelligence (AI) platform built on deep learning and natural language processing (NLP) technologies. Its core products include the DeepSeek-R1 and DeepSeek-V3 models. Leveraging an efficient Mixture...

Stepping Hill Hospital Announced as SPAR…

Stepping Hill Hospital, part of Stockport NHS Foundation Trust, has replaced its bedside units with state-of-the art devices running a full range of information, engagement, communications and productivity apps, to...

DMEA 2025: Digital Health Worldwide in B…

8 - 10 April 2025, Berlin, Germany. From the AI Act, to the potential of the European Health Data Space, to the power of patient data in Scandinavia - DMEA 2025...